Generex Biotechnology competitors

Generex Biotechnology Competitors include Opiant Pharmaceuticals, IntelGenx, Adamas Pharmaceuticals and E-Therapeutics.
Add company...
Generex Biotechnology
Generex Biotechnology
Generex Biotechnology develops and commercializesdrug delivery systems and technologies for metabolic and immunological diseases.
Opiant Pharmaceuticals
Opiant Pharmaceuticals
Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.
IntelGenx
IntelGenx
IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.
Adamas Pharmaceuticals
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
E-Therapeutics
E-Therapeutics
e-Therapeutics is a drug discovery and development company based in Oxford and Newcastle, UK. The Company is a pioneer of network pharmacology, a distinctive new approach to the discovery of medicines.
Founding Date
Founding Date
N/A
Founding Date
2009
Founding Date
2003
Founding Date
2002
Founding Date
2003
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Burlington, CA HQ
Locations
Santa Monica, US HQ
Locations
Saint-Laurent, CA HQ
Locations
Emeryville, US HQ
Locations
Long Hanborough, GB HQ
Employees
Employees
363% decrease
Employees
14367% increase
Employees
12
Employees
8415% increase
Employees
2017% decrease
Valuation ($)
Valuation ($)
3.1 m
Valuation ($)
58.7 m
Valuation ($)
50.1 m
Valuation ($)
287.8 m
Valuation ($)
36.1 m
Twitter followers
Twitter followers
422
Twitter followers
N/A
Twitter followers
1 k
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$703.2k (FY, 2018)
Revenue (est.)
$18.4m (FY, 2017)
Revenue (est.)
$5.2m (FY, 2017)
Revenue (est.)
$571k (FY, 2017)
Revenue (est.)
N/A
Net income
Net income
$35.9m (FY, 2018)
Net income
$6.6m (FY, 2017)
Net income
($3.1m) (FY, 2017)
Net income
($89.5m) (FY, 2017)
Net income
(£5.4m) (FY, 2018)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 1.7m
Total funding raised
$ 82m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Opiant Pharmaceuticals
HQ
Santa Monica, US
Employees
14

Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.

View company
IntelGenx
HQ
Saint-Laurent, CA
Employees
12

IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.

View company
Adamas Pharmaceuticals
HQ
Emeryville, US
Employees
84↑ 15% increase

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

View company
E-Therapeutics
HQ
Long Hanborough, GB
Employees
20↓ 17% decrease

e-Therapeutics is a drug discovery and development company based in Oxford and Newcastle, UK. The Company is a pioneer of network pharmacology, a distinctive new approach to the discovery of medicines.

View company